|
Form Serial Number: |
DA20250509E00374 (Amendment to DA20250507E00432)
|
1.
Date of relevant event: |
07/05/2025 (dd/mm/yyyy)
|
2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
07/05/2025 (dd/mm/yyyy)
|
3.
Stock code: |
02453 |
4.
Name of listed corporation: |
Concord Healthcare Group Co., Ltd. - H Shares |
5.
Class of shares: |
H Shares |
6.
Number of issued shares in class: |
246,551,024 |
7.
Name of director (English) as printed on HKID Card/Passport: |
(Surname) |
YANG |
(Other names) |
Jianyu |
|
|
|
10.
Name of director (Chinese): |
杨建宇 |
11.
Chinese Character Code as printed on HKID Card: |
|
|
24.
Details of relevant event: |
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
Long position |
1101 | The number of shares in which you are interested has increased because: you purchased the shares | |
2201 | Interest of corporation controlled by you | |
2201 | Interest of corporation controlled by you | |
45,600 |
HKD |
6.8400 |
6.8400 |
|
|
Short position |
|
|
|
|
|
|
|
|
|
|
|
25.
Total shares in listed corporation immediately before the relevant event: |
| Total number of shares | Percentage figure (%) |
Long position | 96,518,100 | 39.15 |
|
|
26.
Total shares in listed corporation immediately after the relevant event: |
| Total number of shares | Percentage figure (%) |
Long position | 96,563,700 | 39.17 |
|
|
27.
Capacity in which interests disclosed in Box 26 are held: |
Code describing capacity | Number of shares |
2201 | Interest of corporation controlled by you |
| |
|
|
28.
Further information in derivative interests in listed corporation : |
Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
| | | | | | | | | | |
|
|
29.
Further information in relation to interests of children under 18 and/or spouse: |
Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
|
30.
Further information in relation to interests of corporations controlled by Director: |
Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
Morgancreek Investment Holdings Limited | P.O. Box 957, Offshore Incorporations Centre, Road Town, Tortola, British Virgin Islands; British Virgin Islands | YANG Jianyu | 100.00 | N | |
Concord Medical Services Holdings Limited | Scotia Centre, 4th Floor, P.O. Box 2804, George Town, Grand Cayman KY1-1112, Cayman Islands; Cayman Islands | Morgancreek Investment Holdings Limited | 73.20 | N | |
Ascendium Group Limited | P.O. Box 957, Offshore Incorporations Centre, Road Town, Tortola, British Virgin Islands; British Virgin Islands | Concord Medical Services Holdings Limited | 100.00 | N | |
Medstar (Shanghai) Enterprise Management Co., LTD | Room 116, 1/F, No. 56, Meisheng Road, Pilot Free Trade Zone, Shanghai, PRC; People's Republic of China | Ascendium Group Limited | 98.19 | N | |
Tianjin Concord Medical Technology Co., Ltd. | K52. 11/F, Door 2, Block D, No. 1 Gonghua Road, Huayuan Industrial Zone, Binhai High Tech Zone, Tianjin, PRC; People's Republic of China | Medstar (Shanghai) Enterprise Management Co., LTD | 100.00 | Y | |
Concord Hospital Management Group Limited | Room 1701, 9 Chong Yip Street, Kwun Tong, Kowloon, Hong Kong; Hong Kong | Ascendium Group Limited | 100.00 | N | |
Beijing Concord Medical Technology Co., Ltd. | Room 2702, Block A, No. 36, North Third Ring East Road, Dongcheng District, Beijing, PRC; People's Republic of China | Concord Hospital Management Group Limited | 100.00 | Y | |
Medstar (Shanghai) Enterprise Management Co., LTD | Room 116, 1/F, No. 56, Meisheng Road, Pilot Free Trade Zone, Shanghai, PRC; People's Republic of China | Ascendium Group Limited | 98.19 | Y | |
|
|
31.
Further information in relation to interests held by Director jointly with another person: |
Name of joint shareholder | Address | Number of shares |
| | |
|
|
32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
Names of Trust | Address | Status code | Number of shares |
| | | |
|
|
33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
Names of other parties | Address | Number of shares |
| | |
Total number of shares in which a director is interested under sections 317 and 318 | |
|
|
34.
Supplementary information: |
Medstar (Shanghai) Enterprise Management Co., LTD (醫學之星(上海)企業管理有限公司) has purchased a total of 45,600 H shares of the listed corporation from the open market for an aggregate consideration of HK$311,904.00 at the price of HK$6.84 per share on May 7, 2025. Please refer to the announcement of the listed corporation dated May 7, 2025 for details.
|
35.
Log/Serial Number of the previous form: |
DA20250507E00432
|
36.
Number of concert party document(s) under section 317 attached/uploaded: |
|
Date of filing this Form 3A: |
09/05/2025 (dd/mm/yyyy)
|
|